Comprehensive translational EU funded doctoral network harnessing lipid metabolism to improve prostate cancer management and educate young researchers.
Joined June 2024
- Tweets 4
- Following 41
- Followers 17
- Likes 5
1 Photos and videos
PROSTAMET_MSCA retweeted
19 Jan 2025
I am happy to share our review on #prostatecancer #epigenetics published in the last issue of @NatRevUrol
pubmed.ncbi.nlm.nih.gov/3982…
#CIIPOP
@GEBC_IPOPorto
@IPOPorto
@Uroweb
@EACR
@AACR
@isMOCLEP
@PROSTAMET
@ASPICancro
@apurologia
@SociedadeSpo
ALT Evolution of prostate cancer (PCa) and associated epigenetic changes at different disease stages (localized PCa, castration-resistant PCa (CRPC), and neuroendocrine PCa), along with potential epidrug classes for administration in CRPC and neuroendocrine PCa stages. Abbreviations: BET - Bromodomain and extraterminal motif; CRPC – Castration-resistant Prostate Cancer; DNMT - DNA methyltransferases; Epidrug – Epigenetic drug; HAT - Histone acetyltransferases; HDAC - histone deacetylases; LncRNA – long non-coding RNA; miRNA- microRNA; PCa – Prostate Cancer.
1
12
30
3,641
8 Jan 2025
Great Science and training at the PROSTAMET Kick-off meeting in Toulouse.
1
6
147
PROSTAMET_MSCA retweeted
7 Jan 2025
We are pleased to announce the Kick-off meeting of the MSCA-DN PROSTAMET this week in Toulouse. Exciting scientific sessions and training as well as networking.
4
17
601
1 Jul 2024
🚀 We're excited to introduce PROSTAMET, an MSCA EU-funded Doctoral Network dedicated to improving prostate cancer management through lipid metabolism research.
#ProstateCancer #PhD #MSCA #LipidMetabolism #PrecisionMedicine #ResearchAndTraining
2
5
771